ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 134 filers reported holding ANIKA THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $27,945 | -28.3% | 1,500 | 0.0% | 0.00% | – |
Q2 2023 | $38,970 | -9.5% | 1,500 | 0.0% | 0.00% | – |
Q1 2023 | $43,080 | -3.0% | 1,500 | 0.0% | 0.00% | – |
Q4 2022 | $44,400 | +23.3% | 1,500 | 0.0% | 0.00% | – |
Q3 2022 | $36,000 | +9.1% | 1,500 | 0.0% | 0.00% | – |
Q2 2022 | $33,000 | -13.2% | 1,500 | 0.0% | 0.00% | – |
Q1 2022 | $38,000 | -29.6% | 1,500 | 0.0% | 0.00% | – |
Q4 2021 | $54,000 | -15.6% | 1,500 | 0.0% | 0.00% | – |
Q3 2021 | $64,000 | -1.5% | 1,500 | 0.0% | 0.00% | – |
Q2 2021 | $65,000 | +6.6% | 1,500 | 0.0% | 0.00% | – |
Q1 2021 | $61,000 | -10.3% | 1,500 | 0.0% | 0.00% | – |
Q4 2020 | $68,000 | +28.3% | 1,500 | 0.0% | 0.00% | – |
Q3 2020 | $53,000 | -7.0% | 1,500 | 0.0% | 0.00% | -100.0% |
Q2 2020 | $57,000 | +32.6% | 1,500 | 0.0% | 0.00% | – |
Q1 2020 | $43,000 | -44.9% | 1,500 | 0.0% | 0.00% | -100.0% |
Q4 2019 | $78,000 | -4.9% | 1,500 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $82,000 | +34.4% | 1,500 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $61,000 | +35.6% | 1,500 | 0.0% | 0.00% | – |
Q1 2019 | $45,000 | -10.0% | 1,500 | 0.0% | 0.00% | -100.0% |
Q4 2018 | $50,000 | -20.6% | 1,500 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $63,000 | +31.2% | 1,500 | 0.0% | 0.00% | – |
Q2 2018 | $48,000 | -36.0% | 1,500 | 0.0% | 0.00% | -100.0% |
Q1 2018 | $75,000 | -7.4% | 1,500 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $81,000 | +11.0% | 1,500 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $73,000 | +1.4% | 1,500 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $72,000 | -10.0% | 1,500 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $80,000 | +19.4% | 1,500 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $67,000 | +17.5% | 1,500 | 0.0% | 0.00% | 0.0% |
Q4 2015 | $57,000 | +18.8% | 1,500 | 0.0% | 0.00% | – |
Q3 2015 | $48,000 | -4.0% | 1,500 | 0.0% | 0.00% | – |
Q2 2015 | $50,000 | -19.4% | 1,500 | 0.0% | 0.00% | -100.0% |
Q1 2015 | $62,000 | +1.6% | 1,500 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $61,000 | +10.9% | 1,500 | 0.0% | 0.00% | – |
Q3 2014 | $55,000 | -20.3% | 1,500 | 0.0% | 0.00% | -100.0% |
Q2 2014 | $69,000 | +11.3% | 1,500 | 0.0% | 0.00% | – |
Q1 2014 | $62,000 | -22.5% | 1,500 | -28.6% | 0.00% | -100.0% |
Q4 2013 | $80,000 | – | 2,100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Portolan Capital Management | 217,105 | $10,058,000 | 2.20% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 284,393 | $13,175,000 | 0.88% |
AMI ASSET MANAGEMENT CORP | 183,494 | $8,501,000 | 0.84% |
CAPITAL MANAGEMENT CORP /VA | 49,765 | $2,306,000 | 0.74% |
TFS CAPITAL LLC | 105,839 | $4,904,000 | 0.39% |
Baltimore-Washington Financial Advisors, Inc. | 24,390 | $1,130,000 | 0.35% |
OBERWEIS ASSET MANAGEMENT INC/ | 27,600 | $1,279,000 | 0.32% |
Stephens Investment Management Group LLC | 192,650 | $8,925,000 | 0.27% |
THOMPSON SIEGEL & WALMSLEY LLC | 263,622 | $12,214,000 | 0.24% |
DIKER MANAGEMENT LLC | 21,200 | $982,000 | 0.22% |